Article info

Download PDFPDF
Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections

Authors

  1. Correspondence to Richard Gale, Academic Unit of Ophthalmology, York Teaching Hospital NHS Foundation Trust, York, UK; richard.gale{at}york.nhs.uk
View Full Text

Citation

Gale R, Gill C, Pikoula M, et al
Multicentre study of 4626 patients assesses the effectiveness, safety and burden of two categories of treatments for central retinal vein occlusion: intravitreal anti-vascular endothelial growth factor injections and intravitreal Ozurdex injections

Publication history

  • Received June 29, 2020
  • Revised August 11, 2020
  • Accepted August 18, 2020
  • First published September 22, 2020.
Online issue publication 
October 21, 2021

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.